EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Efficacy of N-Acetylcysteine as an Adjuvant Therapy for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Tingting He, Kehui Ren, Li Xiang, Huan Yao, Yucheng Huang, Yongxiang Gao

British Journal of Hospital Medicine · 2024

DOI: 10.12968/hmed.2024.0560 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift British Journal of Hospital Medicine, 2024. Verfasst von Tingting He und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Acetylcysteine, Arthritis, Rheumatoid, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Background Rheumatoid arthritis (RA) is an inflammatory autoimmune disease and N-acetylcysteine (NAC) is considered a potential therapeutic agent for RA due to strong antioxidant and anti-inflammatory properties. Therefore, this systematic review and meta-analysis aimed to evaluate the efficacy of NAC as an adjuvant therapy for RA.

Methods

A systematic search was conducted across five databases from inception to 1 August 2024, including CINAHL, Cochrane Library, EMBASE, PubMed, and Web of Science. The Cochrane risk-of-bias tool for randomized trials was used to assess the quality of the included studies. Sensitivity analysis was performed when significant heterogeneity was identified.

Results

Four studies involving 204 patients were included in our meta-analysis. The results indicated that NAC alleviated disease activity in RA patients (Disease Activity Score 28-erythrocyte sedimentation rate (DAS28-ESR): mean difference (MD) = 0.54). Additionally, NAC reduced inflammatory markers (erythrocyte sedimentation rate (ESR): MD = 3.00). However, the beneficial effects of NAC on oxidative stress in RA patients were not observed.

Conclusion

This meta-analysis demonstrated the efficacy of NAC in reducing inflammatory markers, improving joint tenderness, and swelling in patients with RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetylcysteineArthritis, RheumatoidRandomized Controlled Trials as TopicHumansAntioxidantsBlood SedimentationTreatment Outcome

Stichwörter der Autor:innen

N-acetylcysteineinflammationmeta-analysisoxidative stressrheumatoid arthritis

Substanzen

AcetylcysteineAntioxidants

Autor:innen und Institutionen

  • School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
  • Sichuan Provincial Engineering Research Center of Innovative Re-development of Famous Classical Formulas, Pengzhou, Sichuan, China.

Zitieren

APA

He, T., Ren, K., Xiang, L., Yao, H., Huang, Y., & Gao, Y. (2024). Efficacy of N-Acetylcysteine as an Adjuvant Therapy for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2024.0560

Vancouver

He T, Ren K, Xiang L, Yao H, Huang Y, Gao Y. Efficacy of N-Acetylcysteine as an Adjuvant Therapy for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. British Journal of Hospital Medicine. 2024. doi:10.12968/hmed.2024.0560

BibTeX
@article{He2024,
  author = {He, Tingting and Ren, Kehui and Xiang, Li and Yao, Huan and Huang, Yucheng and Gao, Yongxiang},
  title = {Efficacy of N-Acetylcysteine as an Adjuvant Therapy for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
  journal = {British Journal of Hospital Medicine},
  year = {2024},
  doi = {10.12968/hmed.2024.0560}
}
Kostenlos starten →